
OrganiGram Holdings OGI
$ 1.85
-3.91%
Annual report 2024
added 12-13-2025
OrganiGram Holdings Total Shareholders Equity 2011-2025 | OGI
Annual Total Shareholders Equity OrganiGram Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 300 M | 327 M | 185 M | - | - | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 327 M | 185 M | 270 M |
Quarterly Total Shareholders Equity OrganiGram Holdings
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 480 M | - | - | - | 300 M | - | - | - | 327 M | - | - | - | 185 M | - | - | - | 82.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CAD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 480 M | 82.9 M | 275 M |
Total Shareholders Equity of other stocks in the Drug manufacturers industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
46.2 M | - | - | $ 142 M | ||
|
Assertio Holdings
ASRT
|
138 M | $ 0.75 | -2.02 % | $ 53.3 M | ||
|
Aerie Pharmaceuticals
AERI
|
-17.3 M | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
487 M | $ 1.66 | -4.48 % | $ 179 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
8 M | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-808 K | - | 0.86 % | $ 117 M | ||
|
Agile Therapeutics
AGRX
|
-16.3 M | - | 10.11 % | $ 58.2 M | ||
|
Aurora Cannabis
ACB
|
2.13 B | $ 5.22 | -3.33 % | $ 86.3 M | ||
|
Catalent
CTLT
|
3.6 B | - | - | $ 11.5 B | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
1.01 B | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
557 M | - | 2.45 % | $ 38.1 M | ||
|
DURECT Corporation
DRRX
|
14.8 M | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
234 M | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
-6.6 B | - | - | $ 28.9 M | ||
|
Emergent BioSolutions
EBS
|
649 M | $ 11.91 | 4.29 % | $ 610 M | ||
|
Organogenesis Holdings
ORGO
|
263 M | $ 4.91 | 1.76 % | $ 647 M | ||
|
Pacira BioSciences
PCRX
|
778 M | $ 26.42 | 0.49 % | $ 1.22 B | ||
|
Evoke Pharma
EVOK
|
-2.58 M | $ 10.97 | 0.18 % | $ 36.7 M | ||
|
Athenex
ATNX
|
-6.51 M | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
73.8 M | $ 21.45 | 0.4 % | $ 2.04 B | ||
|
Rockwell Medical
RMTI
|
21.3 M | $ 0.9 | -2.78 % | $ 21 M | ||
|
Evolus
EOLS
|
5.52 M | $ 7.2 | 2.2 % | $ 447 M | ||
|
Harrow Health
HROW
|
70.8 M | $ 46.39 | -1.43 % | $ 1.51 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
4.41 M | $ 3.55 | -1.11 % | $ 4.41 M | ||
|
China Pharma Holdings
CPHI
|
7.75 M | $ 1.53 | -1.92 % | $ 26.7 M | ||
|
Bausch Health Companies
BHC
|
-1.02 B | $ 6.79 | -1.95 % | $ 2.48 B | ||
|
Veru
VERU
|
32.3 M | $ 2.39 | -1.15 % | $ 322 M | ||
|
Lannett Company
LCI
|
-251 M | - | 1.15 % | $ 7.11 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
22.9 M | $ 2.96 | 17.0 % | $ 41.6 M | ||
|
Neoleukin Therapeutics
NLTX
|
186 M | - | - | $ 193 M | ||
|
Solid Biosciences
SLDB
|
137 M | $ 5.79 | -1.36 % | $ 236 M | ||
|
PetIQ
PETQ
|
223 M | - | 1.64 % | $ 400 M | ||
|
Relmada Therapeutics
RLMD
|
85.4 M | $ 4.05 | -0.25 % | $ 122 M | ||
|
Jupiter Wellness
JUPW
|
-2.17 M | - | - | $ 33.6 M | ||
|
Perrigo Company plc
PRGO
|
4.32 B | $ 12.99 | -1.14 % | $ 1.78 B | ||
|
ProPhase Labs
PRPH
|
63.6 M | $ 0.11 | -0.35 % | $ 1.74 M | ||
|
Radius Health
RDUS
|
-252 M | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
58.7 M | - | -4.76 % | $ 65.3 M | ||
|
cbdMD
YCBD
|
1.96 M | $ 1.59 | 30.33 % | $ 6.86 M | ||
|
Sundial Growers
SNDL
|
270 M | $ 2.09 | -5.49 % | $ 3.37 M | ||
|
OptiNose
OPTN
|
-86.6 M | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
35.7 M | - | -27.8 % | $ 2.56 M | ||
|
SCYNEXIS
SCYX
|
73 M | $ 0.64 | -1.49 % | $ 30.6 M | ||
|
Tricida
TCDA
|
218 K | - | - | $ 3.25 M | ||
|
Tilray
TLRY
|
3.32 B | $ 11.19 | -7.9 % | $ 6.92 B | ||
|
TherapeuticsMD
TXMD
|
29.3 M | $ 1.74 | -0.86 % | $ 18.2 M | ||
|
Zomedica Corp.
ZOM
|
240 M | - | -0.21 % | $ 98 M | ||
|
Viatris
VTRS
|
21.1 B | $ 11.71 | 0.47 % | $ 14.2 B |